therapy Congestive heart failure is a rare event in patients receiving imatinib

Risto Kerkela, Thomas Force, Recent insights into cardiac hypertrophy and left ventricular remodeling. Current Heart Failure Reports. ,vol. 3, pp. 14- 18 ,(2006) , 10.1007/S11897-006-0026-6

Jorge Cortes, Patricia Ault, Charles Koller, Deborah Thomas, Alessandra Ferrajoli, William Wierda, Mary B. Rios, Laurie Letvak, Elizabeth S. Kaled, Hagop Kantarjian, Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood. ,vol. 101, pp. 4714- 4716 ,(2003) , 10.1182/BLOOD-2003-01-0081

Pawan K. Singal, Natasha Iliskovic, Doxorubicin-Induced Cardiomyopathy The New England Journal of Medicine. ,vol. 339, pp. 900- 905 ,(1998) , 10.1056/NEJM199809243391307

Aaron M. From, Cynthia L. Leibson, Francesca Bursi, Margaret M. Redfield, Susan A. Weston, Steven J. Jacobsen, Richard J. Rodeheffer, Véronique L. Roger, Diabetes in heart failure: prevalence and impact on outcome in the population. The American Journal of Medicine. ,vol. 119, pp. 591- 599 ,(2006) , 10.1016/J.AMJMED.2006.05.024

Risto Kerkelä, Luanda Grazette, Rinat Yacobi, Cezar Iliescu, Richard Patten, Cara Beahm, Brian Walters, Sergei Shevtsov, Stéphanie Pesant, Fred J Clubb, Anthony Rosenzweig, Robert N Salomon, Richard A Van Etten, Joseph Alroy, Jean-Bernard Durand, Thomas Force, Cardiotoxicity of the cancer therapeutic agent imatinib mesylate Nature Medicine. ,vol. 12, pp. 908- 916 ,(2006) , 10.1038/NM1446

Bertrand Condat, Tarik Asselah, David Zanditenas, Bertrande Estampes, Ariel Cohen, Dermot O??Toole, Jo??lle Bonnet, Yann Ngo, Patrick Marcellin, Martine Blazquez, Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C. European Journal of Gastroenterology & Hepatology. ,vol. 18, pp. 287- 289 ,(2006) , 10.1097/00042737-200603000-00010

Hagop Kantarjian, Charles Sawyers, Andreas Hochhaus, Francois Guilhot, Charles Schiffer, Carlo Gambacorti-Passerini, Dietger Niederwieser, Debra Resta, Renaud Capdeville, Ulrike Zoellner, Moshe Talpaz, Brian Druker, None, Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia The New England Journal of Medicine. ,vol. 346, pp. 645- 652 ,(2002) , 10.1056/NEJMOA011573

Christopher D.M. Fletcher, Heikki Joensuu, George D. Demetri, Margaret von Mehren, Charles D. Blanke, Annick D. Van den Abbeele, Burton Eisenberg, Peter J. Roberts, Michael C. Heinrich, David A. Tuveson, Samuel Singer, Milos Janicek, Jonathan A. Fletcher, Stuart G. Silverman, Sandra L. Silberman, Renaud Capdeville, Beate Kiese, Bin Peng, Sasa Dimitrijevic, Brian J. Druker, Christopher Corless, Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. The New England Journal of Medicine. ,vol. 347, pp. 472- 480 ,(2002) , 10.1056/NEJMOA020461

Ken Wyman, Michael B. Atkins, Victor Prieto, Omar Eton, David F. McDermott, Francie Hubbard, Christine Byrnes, Kathleen Sanders, Jeffrey A. Sosman, Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy. Cancer. ,vol. 106, pp. 2005- 2011 ,(2006) , 10.1002/CNCR.21834

Daniel Levy, Martin G Larson, Ramachandran S Vasan, William B Kannel, Kalon KL Ho, The Progression From Hypertension to Congestive Heart Failure JAMA: The Journal of the American Medical Association. ,vol. 275, pp. 1557- 1562 ,(1996) , 10.1001/JAMA.1996.03530440037034